Results 191 to 200 of about 232,421 (202)

Le statu quo n’est plus une option

Canadian Family Physician, 2022
exaly  

PARP-Inhibitor plus NHT als Option

InFo Hämatologie + Onkologie, 2023
exaly  

Bevacizumab Plus Temozolomide: A Novel Treatment Option for Advanced Neuroendocrine Tumors?

Journal of Clinical Oncology, 2013
Anna Koumarianou, Gregory Kaltsas
exaly  

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

Journal of Clinical Oncology, 2020
Nabil Adra, Craig Nichols, Nasser Hanna   +2 more
exaly  

Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases: a Preferential Option for Triple Negative Patients?

Asian Pacific Journal of Cancer Prevention, 2013
Ahmet Dirican, Murat Akyol, Ahmet Alacacioglu   +2 more
exaly  

Are Cholecalciferol plus Anticoagulant Rodenticides a Viable Option for Field Rodents?

Proceedings of the Vertebrate Pest Conference, 2016
Roger Baldwin, Ryan Meinerz, Gary W Witmer   +2 more
exaly  

PHONE COUNSELING PLUS MEDICATION HELP EVEN HEAVY SMOKERS QUIT

Ca-A Cancer Journal for Clinicians, 2006
exaly  

L’utilisation [b]d’internet[/b] en médecine n’est plus une option

Revue Medicale Suisse, 2015
Jean Gabriel Jeannot, Gabriel Jeannot Jean   +1 more
exaly  

La gouvernance des données n’est plus une option

2022
exaly  

Creating a new option for online-only research articles: PNAS Plus

Proceedings of the National Academy of Sciences of the United States of America, 2010
exaly